Invivyd (IVVD) traded up 0.49 % during a 24 hours period ending at 04:03 PM Central Europe on Monday 26th. One Invivyd stock can currently be bought for about USD 0.6 on popular exchanges. Current supply of Invivyd stocks is 295 mn. Invivyd has a current market capitalization of USD 180.8 mn and approximately USD 1.7 mn worth of Invivyd was traded on exchanges in the last 24 hours. Since last month end, Invivyd has traded -32.86 % down. Simple moving average of last 200 days is at USD 1.21. The highest price of past 52 weeks was recorded at USD 3.07 on 11/17/2025. 52 weeks low was at USD 0.53 on 07/31/2026.
Here is how related stocks have performed in the past 24 hours:
Natures Sunshine Prods (NATR) traded down -2.1 % and now trades at USD 12.32. Natures Sunshine Prods has a market capitalisation of USD 213.8 mn. Natures Sunshine Prods has a current price to earnings ratio of 12.11.
Octave Specialty (OSG) traded flat 0 % and now trades at USD 4.8. Current market capitalisation for Octave Specialty is USD 214 mn.
Collective Acquisition (CCAQU) traded flat 0 % and now trades at USD 10.56. Collective Acquisition has a market capitalisation of USD 214.5 mn.
Entergy New Orleans (ENO) traded down -0.74 % and now trades at USD 19.48. Current market capitalisation for Entergy New Orleans is USD 214.6 mn.
Spok (SPOK) traded down -3.83 % and now trades at USD 10.27. Spok has a market capitalisation of USD 215.5 mn. Spok has a current price to earnings ratio of 18.11.
About Invivyd
Invivyd, Inc. is a biotechnology company based in Waltham, United States, which specializes in developing multiple next-generation candidate antibodies for the prevention and treatment of COVID-19. The company has its sights set on bringing two specific molecules, labeled NVD200, through near-term clinical development for combined use. Invivyd serves customers globally, and its official website can be accessed under www.invivyd.com . The company’s stock is traded on the Nasdaq.
